Study of the Relationship Between Glycosylated Hemoglobin, Homa IR and Serum Glucose in Acute Ischemic Stroke in the Diabetic Patient

1. Megherbi, S. E., Milan, C., Minier, D., Couvreur, G., Osseby, G. V., Tilling, K., ... & Giroud, M. (2003). Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke, 34 (3), 688-694.10.1161/01.STR.0000057975.15221.40Search in Google Scholar

2. Suslina, Z. A., Piradov, M. A., & Domashenko, M. A. (2014). Stroke: the review of the problem (15 years later). Zhurnal Neurologists and Psychiatric Hymns SS Korsakova, 114 (11), 5-13.Search in Google Scholar

3. Lieber, B. A., Taylor, B., Appelboom, G., Prasad, K., Bruce, S., Yang, A., ... & Connolly Jr, E. S. (2015). Meta-analysis of telemonitoring to improve HbA1c levels: promise for stroke survivors. Journal of Clinical Neuroscience, 22 (5), 807-811.10.1016/j.jocn.2014.11.009Search in Google Scholar

4. Gentile, N. T., Seftchick, M. W., Huynh, T., Kruus, L. K., & Gaughan, J. (2006). Decreased mortality by normalizing blood glucose after acute ischemic stroke. Academic emergency medicine, 13 (2), 174-180.10.1197/j.aem.2005.08.009Search in Google Scholar

5. Williams, L. S., Rotich, J., Qi, R., Fineberg, N., Spain, A., Bruno, A., ... & Tierney, W. R. (2002). Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology, 59 (1), 67-71.10.1212/WNL.59.1.67Search in Google Scholar

6. Kohler, H. P. (2002). Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss medical weekly, 132 (19-20), 241-252.Search in Google Scholar

7. Marques-Vidal, P., Mazoyer, E., Bongard, V., Gourdy, P., Ruidavets, J. B., Drouet, L., & Ferrières, J. (2002). Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care, 25 (8), 1371-1377.10.2337/diacare.25.8.1371Search in Google Scholar

8. Arcaro, G., Cretti, A., Balzano, S., Lechi, A., Muggeo, M., Bonora, E., & Bonadonna, R. C. (2002). Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation, 105 (5), 576-582.10.1161/hc0502.103333Search in Google Scholar

9. Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A. A., & Vaccaro, O. (1998). Plasma fibrinogen: a new factor of the metabolic syndrome: a population-based study. Diabetes Care, 21 (4), 649-654.10.2337/diacare.21.4.649Search in Google Scholar

10. Haapaniemi, E., Soinne, L., Syrjälä, M., Kaste, M., & Tatlisumak, T. (2004). Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke. Acta neurologica scandinavica, 110 (4), 242-247.10.1111/j.1600-0404.2004.00304.xSearch in Google Scholar

11. Berge, E., Friis, P., & Sandset, P. M. (2001). Hemostatic activation in acute ischemic stroke. Thrombosis research, 101 (2), 13-21.10.1016/S0049-3848(00)00380-7Search in Google Scholar

12. Reeves, M. J., Vaidya, R. S., Fonarow, G. C., Liang, L., Smith, E. E., Matulonis, R., ... & Schwamm, L. H. (2010). Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines – Stroke. Stroke, 41 (5), e409-e417.10.1161/STROKEAHA.109.57269320224058Search in Google Scholar

13. Megherbi, S. E., Milan, C., Minier, D., Couvreur, G., Osseby, G. V., Tilling, K., ... & Giroud, M. (2003). Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke, 34 (3), 688-694.10.1161/01.STR.0000057975.15221.4012624292Search in Google Scholar

14. Kiers, L., Davis, S. M., Larkins, R., Hopper, J., Tress, B., Rossiter, S. C., ... & Ratnaike, S. (1992). Stroke topography and outcome in relation to hyperglycaemia and diabetes. Journal of Neurology, Neurosurgery & Psychiatry, 55 (4), 263-270.10.1136/jnnp.55.4.2634890371583510Search in Google Scholar

15. Anwar, M. M. U., Jahan, S. M. S., Afrin, S., & Hossain, M. Z. (2017). Diabetic and Non-diabetic Subjects with Ischemic Stroke: Risk Factors, Stroke Topography and Hospital Outcome. Journal of Medicine, 18 (2), 75-79.10.3329/jom.v18i2.33684Search in Google Scholar

16. Jørgensen, H., Nakayama, H., Raaschou, H. O., & Olsen, T. S. (1994). Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke, 25 (10), 1977-1984.Search in Google Scholar

17. Wu, S., Wang, C., Jia, Q., Liu, G., Hoff, K., Wang, X., ... & Liu, L. (2014). HbA1c is associated with increased all-cause mortality in the first year after acute ischemic stroke. Neurological research, 36 (5), 444-452.10.1179/1743132814Y.000000035524649851Search in Google Scholar

18. Wu, S., Shi, Y., Wang, C., Jia, Q., Zhang, N., Zhao, X., ... & Investigators for the Survey on Abnormal Glucose Regulation in Patients With Acute Stroke Across China (ACROSS-China. (2013). Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in a Chinese cohort study. PLoS One, 8 (11), e80690.10.1371/journal.pone.0080690382747324236195Search in Google Scholar

19. Jing, J., Pan, Y., Zhao, X., Zheng, H., Jia, Q., Mi, D., ... & He, Y. (2017). Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: the ACROSS-China study (abnormal glucose regulation in patients with acute stroke across China). Stroke, 48 (4), 887-893.10.1161/STROKEAHA.116.01561328235959Search in Google Scholar

20. Roquer, J., Giralt-Steinhauer, E., Cerdà, G., Rodríguez-Campello, A., Cuadrado-Godia, E., Jiménez-Conde, J., ... & Ois, A. (2015 ). Glycated hemoglobin value combined with initial glucose levels for evaluating mortality risk in patients with ischemic stroke. Cerebrovascular diseases, 40 (5-6), 244-250.10.1159/00044073526484656Search in Google Scholar